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Duchenne muscular dystrophy (DMD) is a genetic disease associated with mutations of Dystrophin gene that regulate myofiber
integrity and muscle degeneration, characterized by oxidative stress increase. We previously published that reactive oxygen
species (ROS) induce miR-200c that is responsible for apoptosis and senescence. Moreover, we demonstrated that miR-200c
increases ROS production and phosphorylates p66Shc in Ser-36. p66Shc plays an important role in muscle differentiation; we
previously showed that p66Shc−/− muscle satellite cells display lower oxidative stress levels and higher proliferation rate and
differentiated faster than wild-type (wt) cells. Moreover, myogenic conversion, induced by MyoD overexpression, is more
efficient in p66Shc−/− fibroblasts compared to wt cells. Herein, we report that miR-200c overexpression in cultured myoblasts
impairs skeletal muscle differentiation. Further, its overexpression in differentiated myotubes decreases differentiation indexes.
Moreover, anti-miR-200c treatment ameliorates myogenic differentiation. In keeping, we found that miR-200c and p66Shc
Ser-36 phosphorylation increase in mdx muscles. In conclusion, miR-200c inhibits muscle differentiation, whereas its inhibition
ameliorates differentiation and its expression levels are increased in mdx mice and in differentiated human myoblasts of DMD.
Therefore, miR-200c might be responsible for muscle wasting and myotube loss, most probably via a p66Shc-dependent
mechanism in a pathological disease such as DMD.
1. Introduction
We previously showed that oxidative stress inhibits myo-
genic differentiation [1] and in a model of oxidative stress
such as acute hind limb ischemia, it was demonstrated that
reactive oxygen species (ROS) production plays a causal role
in tissue damage, leading to cell death by both apoptosis and
necrosis [2].
p66Shc adaptor protein is a redox enzyme implicated in
mitochondrial ROS generation and translation of oxidative
signals [3]. Under physiological conditions, the phosphoryla-
tion of Tyr residues of p66Shc by growth factors mediates the
signal transduction to the nucleus, inhibiting the Ras signal-
ing pathway, while phosphorylation of the Ser-36 site is
crucial for oxidative stress response [4]. p66Shc once phos-
phorylated in Ser-36 enhances ROS production by using
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three different mechanisms restricted in the nucleus, the
plasma membrane, and the mitochondria [4].
In keeping, our previous results demonstrated that
p66Shc inhibits myogenic differentiation and p66Shc dele-
tion enhances skeletal muscle regeneration after ischemia [1].
MicroRNAs (miRNAs) are 21–23 nucleotide RNA mole-
cules that regulate stability or translational efficiency of target
messenger RNAs [5]. miRNAs control a wide range of cell
functions and have been associated with inflammation, oxi-
dative stress, and differentiation [6–8].
We previously showed that the miR-200 family is upreg-
ulated upon oxidative stress in different cells, such as endo-
thelial cells, human fibroblasts, murine myoblasts, and
myotubes [9]. This miRNA family consists of five members
(miR-200c, miR-141, miR-200a, miR-200b, and miR-429).
We demonstrated that miR-200c is the most upregulated
family member and is responsible for apoptosis and senes-
cence by targeting zinc finger E-box-binding homeobox 1
(ZEB1) protein [9]. We also demonstrated that miR-200c is
induced following acute hind limb ischemia in skeletal mus-
cles and this induction was oxidative stress dependent, since
in p66Shc−/− mice, which exhibit less oxidative stress than
wild-type (wt) mice [1], miR-200c increase is significantly
attenuated [9].
In a recent publication, we demonstrated that miR-200c
increased ROS production and induced p66Shc protein
phosphorylation in Ser-36; this mechanism upregulated
ROS and inhibited FOXO1 transcription of ROS scavengers,
reinforcing this molecular circuitry [10].
Moreover, we showed that anti-miR-200c treatment in
hind limb ischemia in mice rescued the decrease of miR-
200c protein targets and improved limb perfusion [10].
Herein, we wanted to dissect the role of miR-200c in
muscle differentiation and to comprehend whether miR-
200c levels were modulated in muscle pathological diseases
associated with oxidative stress increase, such as Duchenne
muscular dystrophy (DMD) [11, 12].
In keeping with this hypothesis, in the paper of Greco
et al., an interesting link between ischemia-, mdx-, and
DMD-modulated miRNAs associated with apoptosis/myo-
necrosis was demonstrated [13]. Interestingly, in adductor
muscles of mdx, a miR-200c upregulation was found in a
miRNA screening, although not significantly [13].
Muscular dystrophies are a heterogenous group of genetic
disorders characterized by muscle degeneration and associ-
ated with mutations of genes that regulate myofiber integrity
[14]. The most common dystrophy is the DMD, a lethal
X-linked genetic disease characterized by severe muscle degen-
eration, caused by deficiency of dystrophin, a critical compo-
nent of the dystrophin glycoprotein complex (DGC), acting
as a link between cytoskeleton and extracellular matrix both
in skeletal and cardiac muscles [15, 16]. The mdx mice strain
represents the most used animal model to study DMD [17].
Dystrophic muscles undergo continuous cycles of degen-
eration and regeneration. Satellite cells (SC), the skeletal
muscle stem cells, exit from quiescence and undergo the pro-
liferation phase followed by activation of skeletal muscle dif-
ferentiation program or return to quiescence to maintain the
stem cell pool. Although SC compensate for muscle fiber loss
in the early stages of dystrophy leading to muscle compensa-
tory regeneration, eventually, these progenitors become
exhausted [18]. As a result, muscles are characterized by
necrosis and inflammation culminating in extracellular
matrix and fat deposition. Consequently, fibrous and fatty
connective tissue overtakes the functional myofibers [15, 19].
Recent papers highlighted new cellular and molecular
mechanisms contributing to SC dysfunction in dystrophic
muscle. Specifically, SC hold an intrinsic cell dysfunction
affecting their polarity and asymmetric division [20]. More-
over, SC can undergo mesenchymal fibrogenic conversion,
mediated by TGFbeta signaling, compromising their physio-
logical muscle regenerative functions [21, 22].
The pathology of DMD appears to be exacerbated by oxi-
dative stress, and ROS increase plays a pivotal role in the
necrosis of skeletal muscles in DMD and in dystrophic mdx
mouse [11]. Moreover, since contractile (myofibrillar) pro-
teins such as myosin, actin, troponin, and tropomyosin con-
taining thiol side chains are sensitive to oxidation, these
modifications may alter excitation/contraction coupling and
cross-bridge cycling, modulating muscle contraction. As a
consequence, excessive oxidative stress that occurs in DMD
provokes muscle weakness and wasting [11].
The results of the present work show that miR-200c
impairs muscle differentiation, whereas miR-200c inhibition
ameliorates differentiation; moreover, both miR-200c expres-
sion levels and p66Shc phosphorylation in Ser-36 increase
in mdx mice. Moreover, miR-200c increases also in differ-
entiated human myoblasts of DMD. Therefore, we hypoth-
esized a miR-200c role in muscle wasting and myotube
loss via a p66Shc-dependent mechanism in DMD.
2. Materials and Methods
2.1. Cell Line, Culture Conditions, and Transfections. C2.12
(C2C12), a subclone of the C2 mouse myoblast cell line,
was obtained from M Buckingham. C2C12 were cultured in
growth medium ((GM) DMEM-GlutaMAX complemented
with penicillin/streptomycin and 20% FBS). Myogenic differ-
entiation was induced by shifting the cells in differentiation
medium ((DM) DMEM-GlutaMAX complemented with
penicillin/streptomycin and 2% FBS).
Human myoblasts were derived from muscle biopsies of
healthy donors or DMD patients. Human myoblasts were
cultured in growth medium (GM) (DMEM-GlutaMAX com-
plemented with penicillin/streptomycin and 20% FBS). Myo-
genic differentiation was induced by shifting the cells in
differentiation medium (DM) (DMEM-GlutaMAX comple-
mented with penicillin/streptomycin, 5% horse serum, and
insulin 100μg/ml).
Transfections were carried out by using Lipofectamine
3000 reagent (Invitrogen) according to the manufacturer’s
instructions. Cells were seeded at 105 per well in six-well
dishes and transfected 18 hours (h) later. The amount of plas-
mid used in transfection assay is indicated in thefigure legend.
2.2. Drug Treatments. H2O2 (30% (wt/wt) solution; Sigma)
was administered to the cells as a 100mM solution in
phosphate-buffered saline (PBS).
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2.3. Plasmid Constructs. p66Shc-Ser-36 to Ala mutant was
generated using QuickChange Site-Directed Mutagenesis
Kit (Stratagene) starting from p66Shc pBABE vector.
plko.1-miR-200c and plko.1-anti-miR-200c constructs were
described previously [9, 10].
2.4. miRNA Overexpression and Inhibition. Stable expression
of miR-200c, anti-miR-200c, or miR-scramble in C2C12
cells was generated by viral infection using lentiviral
supernatants. These viruses were produced as previously
described [23]. In summary, cells were infected with lenti-
viral virus for 2 h and then were recovered in complete
fresh medium for 24 h. Afterwards, infected cells were
selected by puromycin-containing medium (Sigma) for
72 h. miR-200c overexpression was controlled by quantita-
tive real-time PCR (RT-qPCR) (see methods below).
2.5. Immunofluorescence of Cultured Cells. C2C12 in culture
were fixed in 4% paraformaldehyde in PBS for 10 minutes
at room temperature, incubated with glycine 50mM in PBS
for 10 minutes at room temperature to quench paraformal-
dehyde, and permeabilized with 0.1% Triton-X in PBS for
10min at room temperature. Then, cells were blocked with
4% IgG-free bovine serum albumin (BSA) in PBS for 30
minutes. Cells were immune labelled with the antibody
against myosin heavy chain (MyHC) (MF20 Hybridoma
bank) in 4% BSA overnight at +4°C. Donkey anti-mouse
IgG conjugated to Alexa Fluor 488 (Jackson ImmunoRe-
search #715-545-150) were used to detect the signal. Nuclei
were counterstained with DAPI (Sigma D9542). Phase
contrast images of C2C12 cells were acquired with Leica
microscope (DM-IRB). Immunofluorescence images were
acquired with confocal laser scanning microscopy system
Zeiss Axiovert 200M or fluorescencemicroscope Nikon Eclipse
TE-2000E. Counts were performed with ImageJ software.
Differentiation index calculations are as follows:
(i) Differentiation index was measured as the percent-
age of all MyHC+ cells, both mononucleated and
multinucleated cells.
(ii) Fusion index was measured as the percentage of
multinucleated MyHC+ cells (≥2 nuclei).
(iii) Nuclei per myotube were calculated as the mean of
the number of nuclei within myotubes.
2.6. Animal Model. Mdx mice (C57BL10J DMDmdx) and
wild-type (wt) mice (C57BL10J) were purchased from
Charles River. All mice handling procedures were approved
by the internal Animal Research Ethical Committee accord-
ing to the Italian Ministry of Health and complied with the
NIH Guide for the Care and Use of Laboratory Animals.
All the procedures were carried out in accordance with the
promise of the three Rs (replacement, reduction, and refine-
ment). The animals were housed in cages with environmental
enrichment in order to reduce pain and stress and increase
animal welfare. The animals were sacrificed, and hind limb
muscles were directly frozen in liquid nitrogen and stored
at −80°C.
2.7. RNA Isolation and qPCR Analysis. Hind limb muscles
from mdx mice were homogenized by a handheld rotor-
stator homogenizer (TissueRuptor—Qiagen) in TRIzol
reagent (Invitrogen). RNA was extracted following manufac-
turer’s protocol (TRIzol—Invitrogen).
Hind limb muscles were isolated from 3 different ani-
mals for each strain and age described in the figures, and
RNA was isolated and quantified by NanoDrop (Thermo
Scientific 2000C).
miRNA levels were analyzed using the TaqMan RT-
qPCR and quantified with the ABI Prism 7000 SDS (Applied
Biosystems). miR-200c levels were normalized to U6 small
RNA expression as previously reported [24, 25].
Primers for miR-200c, U6, and reagents for reverse tran-
scriptase and RT-qPCRs were all obtained from Applied
Biosystems.
2.8. Protein Isolation and Western Blot Analysis. C2C12 cells
were lysed in a buffer containing 100mM Tris (pH6.8), 20%
glycerol, and 4% sodium dodecyl sulfate (SDS). Amounts
of protein were determined by bicinchoninic acid protein
assay kit (Pierce, Rockford, IL). Then dithiothreitol (DTT)
(200mM) was added and lysates were boiled for 5min.
Hind limbmuscles frommdxmicewere homogenized by a
handheld rotor-stator homogenizer (TissueRuptor—Qiagen;
5–10seconds, 4 timesat+4°C) inproteinextractionbuffer con-
taining 50mM Tris-HCl pH7.5, 0.6M sucrose, 50% glycerol,
1% Triton, and 50mM NaCl supplemented with protease
(1mM PMSF, 5μg/ml aprotinin, 5μg/ml leupeptin, and
5μg/ml pepstatin) and phosphatase inhibitors (10mM NaF,
5mM β-glycerophosphate, and 1mM Na-orthovanadate).
Lysates were also sonicated (5 seconds, 2 times), incubated
on a tube rotator at +4°C for 30 minutes, and cleared of insol-
uble debris by centrifugation at 13000 rpm for 20 minutes at
+4°C and the supernatants were stored at −80°C. Protein con-
centrations were determined by Bradford assay.
For Western blot analysis, proteins were extracted from
gastrocnemius and quadricepsmuscles ofwt andmdx animals
(3 wt mice and 3 mdx mice of 4 weeks and 36 weeks, resp.).
Proteins were separated on denaturing SDS-polyacrylamide
gels, transferred to the nitrocellulose membrane by standard
procedures, and blotted with the following primary anti-
bodies: ZEB1 (H-102), myosin heavy chain MyHC (MF20
mouse hybridoma), MyoD (MoAb 5.8A, Dako), myogenin
(IF5D mouse hybridoma), p66Shc (Transduction Laborato-
ries), p66Shc-phospho-Ser-36 (Abcam 6E10), tubulin
(Oncogene Research Products Ab-1), and GAPDH (Calbio-
chem CB1001). The antibody binding was revealed by horse-
radish peroxidase-conjugated secondary antibodies followed
by chemiluminescence detection (ECL, Pierce).
Immunoprecipitations were performed as previously
described [26]. Cells were resuspended in lysis buffer
containing 50mM HEPES (pH7.5), 250mM NaCl, 1mM
DTT, 0.1% Tween 20, 10% glycerol, 5mM CaCl2, 1mM phe-
nylmethylsulfonyl fluoride (PMSF), 10mM Na3VO4, 50mM
NaF, and protease inhibitors (complete EDTA-free protease
inhibitor mixture tablets; Roche Applied Sciences). Immuno-
precipitations were performed for 2 to 3 h at 4°C with protein
A/G agarose and 1μg of relevant antibodies. Immune
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complexes were resuspended in 2x Laemmli buffer, separated
by SDS-polyacrylamide gel electrophoresis (PAGE), and
immunoblotted with relevant antibodies.
2.9. Statistical Analysis. The number of samples or indepen-
dent experiments and the definition of reported values are
indicated in the figure legends as mean± standard error of
the mean (SEM). Statistical analyses were performed using
the GraphPad Prism software (Version 5.0). Statistical signif-
icance was assessed by unpaired Student’s t-test or ANOVA.
P value< 0.05 was considered as statistically significant.
3. Results
3.1. miR-200c Overexpression Inhibits Myogenic Differentiation.
We previously showed that oxidative stress inhibits muscle dif-
ferentiation [1]. We also demonstrated that miR-200c is
highly induced upon H2O2 treatment in C2C12 in both
myoblasts and differentiated myotubes [9]. Therefore, we
asked whether miR-200c modulation had an effect on myo-
genic differentiation.
To this aim, we overexpressed miR-200c in C2C12 myo-
blasts; then, we shifted the cells to differentiation medium
(DM). We found that miR-200c inhibited myotube forma-
tion as assessed by MyHC immunofluorescence staining
(Figure 1(a)). In addition, a decrease of three muscle differen-
tiation parameters was also observed, specifically differentia-
tion index (percentage of both myotubes and MyHC-positive
cells), fusion index (percentage of nuclei within a myotube),
and number of nuclei within myotubes (Figure 1(b)). We
then analyzed myogenic differentiation byWestern blot anal-
ysis, and we observed that ZEB1, MyHC, and myogenin pro-
teins were all downregulated upon miR-200c overexpression,
whereas MyoD was not affected (Figure 1(c)).
miR-200c overexpression was also performed in C2C12
after 24 hrs of myogenic differentiation. As shown in phase
contrast images of Figure 2(a), we started from cells with a
similar degree of differentiation prior to infection (upper
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Figure 1: miR-200c overexpression in myoblasts inhibits skeletal muscle differentiation in vitro. C2C12 myoblasts were infected either with a
lentivirus encoding miR-200c or with a control virus. After selection with puromycin, cells were plated and shifted to differentiation medium
for 3 days. (a) Representative images of anti-MyHC staining (green). Nuclei were counterstained with DAPI (grey). Immunofluorescence with
anti-MyHC antibody showed a decrease in myotubes in miR-200c-overexpressing cells compared to control. Scale bar: 200μm. (b) Bar graphs
representing differentiation index (percentage of MyHC-positive cells), fusion index (percentage of nuclei within a myotube), and number of
nuclei per myotube. miR-200c overexpression decreased all these parameters (n = 3 independent experiments; ∗∗∗p < 0 001). (c) A
representative Western blot using ZEB1, MyHC, myogenin, and antibodies showed that protein levels decreased upon miR-200c
overexpression and MyoD expression was not affected. α-Tubulin (TUB) was used as loading control.
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panels); we found that miR-200c overexpression decreased
the myotube number (Figure 2(a) lower panels), assessed also
by MyHC immunofluorescence staining (Figure 2(b)). More-
over, a decrease in differentiation index, fusion index, and
number of nuclei within myotubes was also observed in dif-
ferentiated miR-200c-overexpressing cells (Figure 2(c)).
We then analyzed myogenic differentiation by Western
blot, and we observed that ZEB1, MyHC, myogenin, and
MyoD proteins were all downregulated upon miR-200c over-
expression (Figure 2(d)).
All these results suggested a role for miR-200c in myo-
genic differentiation inhibition and in myotube loss.
3.2. miR-200c Inhibition Enhances Myogenic Differentiation.
We then asked whether anti-miR-200c treatment was able to
ameliorate myogenic differentiation. Therefore, we transduced
C2C12 cells with anti-miR-200c lentiviral particles and
we shifted cells to DM for increasing period of times.
We found that anti-miR-200c increased myotube forma-
tion as assessed by MyHC immunofluorescence staining
(Figure 3(a)). In addition, an increase of three muscle dif-
ferentiation parameters was also observed, specifically dif-
ferentiation index, fusion index, and number of nuclei
within myotubes (Figure 3(b)). We analyzed myogenic dif-
ferentiation by Western blot, and we found that MyHC,
myogenin, and MyoD proteins were increased at 48 h and
72 h of DM upon anti-miR-200c expression at higher levels
compared to anti-scramble-treated C2C12 (Figure 3(c)).
3.3. miR-200c Increased p66Shc Phosphorylation in Ser-36 in
C2C12 Myoblasts.We previously showed that, in endothelial
cells, miR-200c induces p66Shc phosphorylation in Ser-36, a
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Figure 2: miR-200c overexpression in myotubes inhibits skeletal muscle differentiation in vitro. C2C12 myoblasts were shifted to
differentiation medium for 24 hrs; then, cells were infected either with a lentivirus encoding miR-200c or with a control virus. Afterwards,
cells were selected with puromycin in differentiation medium for 3 days. (a) Representative-phase contrast images of C2C12 myoblasts
prior to infection (upper panels) and after infection (lower panels). (b) Representative images of anti-MyHC staining (green). Nuclei were
counterstained with DAPI (grey). Scale bar: 200 μm. (c) Bar graphs representing differentiation index, fusion index, and number of nuclei
per myotube. miR-200c overexpression decreased all these parameters (n = 3 independent experiments; ∗∗∗p < 0 001). (d) A representative
Western blot using ZEB1, MyHC, myogenin, and MyoD antibodies showed that protein levels decreased upon miR-200c overexpression.
α-Tubulin (TUB) was used as loading control.
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phosphorylation known to be elicited by oxidative stress [10].
We therefore asked whether miR-200c phosphorylated
p66Shc in this residue, also in C2C12 myoblasts. To this
aim, we transduced C2C12 with miR-200c and scramble con-
trol and then transfected the cells with a p66Shc wt cells or a
mutated p66 (p66mut) plasmid in which Ser-36 was replaced
with Ala, that is not phosphorylable. We treated cells with or
without 400μM H2O2 for 5minutes, and we found that
Ser-36 phosphorylation increased, as expected, upon H2O2
treatment in p66wt-transfected cells, but not in the
p66mut-transfected ones (Figures 4(a) and 4(b)). Moreover,
in C2C12-overexpressing miR-200c, p66wt was phosphory-
lated also in basal conditions, that is, without H2O2, and
the phosphorylation in Ser-36 increased even further upon
H2O2 treatment (Figures 4(a) and 4(b)).
Further, we aimed at establishing whether endogenous
p66 was phosphorylated in Ser-36 by miR-200c. Unfortu-
nately, we failed to visualize phosphorylation by Western
blot analysis; therefore, we immunoprecipitated p66Shc,
to enhance the signal of Ser-36 phosphorylation.
As shown in Figure 4c, we found an increase in Ser-36
phosphorylation in the immunoprecipitates of p66 in miR-
200c-overexpressing C2C12 compared to scramble control
(Figures 4(c) and 4(d)).
Taken together, these results indicate that miR-200c
enhances p66Shc phosphorylation in Ser-36 as well as in
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Figure 3: Anti-miR-200c treatment enhances skeletal muscle differentiation in vitro. C2C12 myoblasts were infected either with a lentivirus
encoding anti-miR-200c or with a control virus. After selection with puromycin, cells were plated and shifted to differentiation medium for
the times indicated in the figure. (a) Representative images of anti-MyHC staining (green). Nuclei were counterstained with DAPI (blue).
Immunofluorescence with anti-MyHC antibody showed an increase in myotubes in anti-miR-200c-overexpressing cells compared to
control at 3 days in DM. Scale bar: 100 μm. (b) Bar graphs representing differentiation index, fusion index, and number of nuclei
per myotube. Anti-miR-200c overexpression increased all these parameters (n = 3 independent experiments; ∗∗∗p < 0 001). (c) A
representative Western blot using MyHC, myogenin, and MyoD antibodies showed that all these protein levels increased upon anti-
miR-200c overexpression. α-Tubulin (TUB) was used as loading control.
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C2C12 myoblasts, supporting its role in oxidative stress pro-
duction [10].
3.4. miR-200c and p66Shc Phosphorylation in Ser-36 Increase
in Skeletal Muscles of mdx Mice.Muscle degeneration inmdx
mice is characterized by high oxidative stress [11]; therefore,
we asked whether miR-200c was induced in mdx mice com-
pared to wt mice.
We analyzed miR-200c expression levels in different
muscles, that is, quadriceps (Q), gastrocnemius (GA), tibialis
anterior (TA), extensor digitorum longus (EDL), and soleus
(SOL), in both young (4-week-old mice (4w)) and older mice
(36-week-old mice (36w)) (Figures 5(a) and 5(b)). We found
that miR-200c was significantly higher in mdx mice com-
pared to wt, in all muscle groups examined, both in young
and older mice (Figures 5(a) and 5(b)); indeed, in Q of young
(~6-fold) and in GA of older mice (~12-fold), we found a
very high increase of miR-200c expression (Figures 5(a)
and 5(b)). An increase of miR-200c expression was also
found in human myoblasts derived from muscle biopsies of
DMD patients cultured in muscle differentiation medium,
compared to human-differentiated myoblasts derived from
muscle biopsies of healthy donors (Figure 5(c)).
In light of these results, we examined the levels of p66Shc
phosphorylation in Ser-36 in Q and GA.
Interestingly, we found an increase of p66 protein in
young mdx compared to wt mice and a strong upregulation
of Ser-36 phosphorylation (Figure 5(d)). Notably, p66 phos-
phorylation in Ser-36 was increased in older mice also in
basal conditions and was even higher in Q and particularly
in GA, showing that older mice displayed higher miR-200c
(Figure 5(d)).
These results suggest a role for miR-200c in oxidative
stress increase in mdx mice, mediated, at least in part, by
p66Shc-dependent mechanism.
4. Discussion
In this report, we dissected the role of the oxidative stress-
induced miR-200c on muscle differentiation, since our and
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Figure 4: miR-200c overexpression induces p66Shc phosphorylation in Ser-36. C2C12 myoblasts were infected either with a lentivirus
encoding miR-200c or with a control virus. After selection with puromycin, cells were transfected with 1μg of p66wt or a mutated version
in which Ser-36 was substituted with Ala that was no longer phosphorylable (p66mut). (a) A representative Western blot using p66Shc-
Ser-36 antibody showed that p66wt phosphorylation was higher in miR-200c-overexpressing cells compared to scramble control both
without and with H2O2 treatment. Phosphorylation of p66mut was not present, as expected, in any condition. α-Tubulin (TUB) was used
as loading control. (b) Bar graph showing the quantification of p66Shc phosphorylation in Ser-36 versus p66wt protein levels of C2C12-
overexpressing miR-200c compared with control cells (n = 3; ∗∗∗p < 0 001). (c) C2C12 myoblasts were infected either with a lentivirus
encoding miR-200c or with a control virus. After selection with puromycin, cells were immunoprecipitated (Ip) with either an anti-p66
antibody or an irrelevant isotypic antibody (negative control). Western blotting with a p66Shc-phospho-Ser-36 antibody revealed that
p66Shc was more phosphorylated in Ser-36 in miR-200c IP-p66 than in scramble control cells. The efficiency of immunoprecipitation was
assessed with an anti-p66 antibody. One-twentieth of the immunoprecipitated whole-cell extract (input) was loaded as a reference. (d) Bar
graph showing the quantification of p66Shc phosphorylation in Ser-36 versus p66 total protein levels of C2C12-overexpressing miR-200c
compared with scramble control cells (n = 3; ∗∗∗p < 0 001).
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other laboratories reported a decrease in myogenic differenti-
ation upon oxidative stress in vitro [1, 27–29].
Our results showed that miR-200c inhibits myogenic
differentiation when forced miR-200c overexpression was
performed in myoblasts; moreover, when miR-200c is over-
expressed in differentiated myotubes, a decrease in myotube
number and size was also observed. These effects are associ-
ated with a decrease in myogenic markers, that is, MyHC
and myogenin, both in growing and in differentiating
conditions. In keeping, anti-miR-200c treatment in grow-
ing myoblasts accelerates myogenic differentiation, increas-
ing myotube numbers and size. We previously found that
miR-200c induces oxidative stress and p66Shc phosphory-
lation in Ser-36 in endothelial cells [10]. In the present study,
we confirmed these results also in murine myoblasts. Further,
we found that both miR-200c and p66Shc phosphorylation in
Ser-36 increase in mdx muscles compared to wt. Moreover,
we found that miR-200c is significantly induced in human-
differentiated myoblasts of DMD patients compared to dif-
ferentiated myoblasts of healthy donors.
Other papers evaluated miRNA expression modulation
in mdx and DMD muscles and also in sera [13, 30]. Indeed,
Greco et al. found that in adductor muscles of mdx, a miR-
200c upregulation was present, although not significant
[13]. Moreover, the authors demonstrated that degenerative
miRNAs may regulate, at least in part, critical mediators of
cell death, contributing to the apoptotic/necrotic myofiber
loss associated with both ischemia and DMD [13]. Our pre-
vious data show that miR-200c is highly induced by ischemia
and its inhibition is able to increase limb perfusion, reverting
the downregulation of its targets responsible of apoptosis,
senescence, ROS increase, and nitric oxide (NO) decrease
[10]. In keeping, the present study demonstrates that miR-
200c that we previously showed to be upregulated upon
ischemia [9, 10] is associated with myotube loss and is upreg-
ulated in mdx and DMD.
Our previous studies demonstrated that p66Shc−/− SC
differentiated better than wt cells in terms of myogenic
marker increase, that is, myogenin and MyHC and myotube
numbers, assessed by MyHC fluorescence; further, myogenic
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Figure 5: miR-200c and p66Shc phosphorylation in Ser-36 increase in dystrophic muscles of mdx mice. (a) The mRNA of quadriceps (Q),
gastrocnemius (GA), tibialis anterior (TA), extensor digitorum longus (EDL), and soleus (SOL) muscles isolated from 3 young (4-week-old
(4 w)) mdx mice were assayed for miR-200c expression. miR-200c increased in young mdx mice compared to young wt mice (n = 3 for each
muscle; ∗p < 0 05; the bar graphs are average results of miR-200c expression levels of 3 different mice for each muscle). (b) The mRNA of
quadriceps (Q), gastrocnemius (GA), tibialis anterior (TA), extensor digitorum longus (EDL), and soleus (SOL) muscles isolated from 3
old (36-week-old (36w)) mdx mice were assayed for miR-200c expression. miR-200c increased in old mdx mice compared to old wt mice
(n = 3 for each muscle; ∗∗p < 0 01; ∗p < 0 05; the bar graphs are average results of miR-200c expression levels of 3 different mice for each
muscle). (c) The mRNA of human myoblasts derived from muscle biopsies of healthy donors or DMD patients and differentiated in vitro
were assayed for miR-200c expression. miR-200c increased in DMD myoblasts compared to control myoblasts (n = 3; ∗p < 0 05; the bar
graphs are average results of miR-200c expression levels of 3 different cell populations for control or DMD samples). (d) A representative
Western blot of GA and Q protein extracts of both young (4w) and old mdx (36w) compared to young and old wt mice showed that p66
protein was induced in mdx mice compared to wt mice. Moreover, the phosphorylation in Ser-36 was induced in mdx mice compared to
wt mice in both young and old mice (the experiment was performed on 3 biological replicates; 3 wt mice and 3 mdx mice of 4 weeks and
36 weeks, resp.). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as loading control.
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conversion, induced by MyoD overexpression, was more effi-
cient in p66Shc−/− fibroblasts compared to wt cells [1]. The
explanation for this, was ascribed to lower oxidative stress
in p66Shc−/− cells compared to wt cells. In addition, it is
possible that NO plays a positive role in higher and faster
myogenic regeneration potential of p66Shc−/−mice and cells.
Indeed, NO mediates SC activation [31] and it is required for
myoblast fusion [32]. Since ROS rapidly react with NO,
generating nitrogen species, such as peroxynitrite [33], it is
conceivable that p66Shc deletion enhances nitric oxide bio-
availability [34], thus, favoring myogenic differentiation.
DMD is a genetic disease caused by deficiency of dystro-
phin, a critical component of theDGC, acting as a linkbetween
cytoskeleton and extracellular matrix in skeletal and cardiac
muscles [15, 16].Adirect consequenceof theDGC inefficiency
is muscle fragility, contraction-induced damage, necrosis,
reduced NO [35], oxidative stress, and inflammation.
In keeping, different preclinical studies in mdx mice
report benefits, that is, decreased necrosis and improved
muscle pathology, for many antioxidant drugs and interven-
tions [11].
Resveratrol, among others, is an antioxidant drug that
has a positive role on DMD [36]; interestingly, it is a potent
activator of sirtuin1 (SIRT1). Moreover, SIRT1 overexpres-
sion in muscle reverses the phenotype of mdx mice [37].
SIRT1 is a NAD+-dependent deacetylase that displays
antioxidant properties and enhances NO bioavailability [38].
Our recent report demonstrated that miR-200c targets
directly SIRT1 and also two important proteins that modu-
late NO production and ROS scavenger transcription, that
is, endothelial nitric oxide synthase (eNOS) and FOXO1.
Therefore, we showed that miR-200c upregulation decreases
NO, increases ROS production, and induces p66Shc protein
phosphorylation in Ser-36; this, in turn, induces ROS via dif-
ferent mechanisms, one of which is the inhibition of FOXO1
transcription of ROS scavengers, reinforcing this molecular
circuitry [10].
Taken together, these results suggest a pivotal role of
miR-200c in oxidative stress induction in DMD via a
p66Shc-dependent mechanism. miR-200c upregulation
might contribute to the establishment of the negative conse-
quences associated with this muscle disease, such as muscle
wasting, lack of muscle regeneration, necrosis, NO decrease,
and oxidative stress increase.
5. Conclusion
p66Shc phosphorylation in Ser-36 is increased in mdx mus-
cles, and miR-200c expression levels are upregulated both in
mdx muscles and in differentiated human myoblasts of
DMD.Although further experiments should be accomplished
in order to point to miR-200c as a therapeutic target, these
data strongly suggest its possible involvement inmuscle wast-
ing in DMD, through apoptosis and senescence induction, as
well as, by the induction of ROS and the decrease of NO.
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